- IN₹139.66bn
- IN₹137.01bn
- IN₹20.13bn
- 58
- 12
- 82
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 37.6 | ||
| PEG Ratio (f) | 5.81 | ||
| EPS Growth (f) | 6.92% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.79 | ||
| Price to Tang. Book | 16.81 | ||
| Price to Free Cashflow | 54.62 | ||
| Price to Sales | 7.18 | ||
| EV to EBITDA | 31.32 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 46.62% | ||
| Return on Equity | 33.45% | ||
| Operating Margin | 20.67% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 29,019 | 29,566 | 27,701 | 19,961 | 20,132 | 21,468 | 23,095 | -8.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +11.51 | +12.4 | -7.7 | -33.17 | -3.44 | +17.2 | -11.91 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
Directors
- Aditya Narayan NEC
- Vaibhav Karandikar CFO
- Radhika Shah CCO
- Rajaram Narayanan MDR (53)
- Cherian Mathew EDR
- A. Sood EDR
- Charles Billard NED
- F. Briens NED (55)
- Rangaswamy Iyer IND (62)
- Usha Thorat IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 2nd, 1956
- Public Since
- November 28th, 1994
- No. of Shareholders
- 68,356
- No. of Employees
- 991
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India- Shares in Issue
- 23,030,622
- Address
- 54/A, MUMBAI, 400072
- Web
- https://www.sanofi.com/en/india
- Phone
- +91 2228032000
- Contact
- Radhika Shah
- Auditors
- Price Waterhouse Chartered Accountants LLP
Upcoming Events for SANOFI
Q1 2026 Sanofi India Ltd Earnings Release
Q2 2026 Sanofi India Ltd Earnings Release
Similar to SANOFI
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Sanofi India share price?
As of Today at 23:04 UTC, shares in Sanofi India are trading at IN₹6,273.00. This share price information is delayed by 15 minutes.
How has the Sanofi India share price performed this year?
Shares in Sanofi India last closed at IN₹6,273.00 and the price had moved by +23.01% over the past 365 days. In terms of relative price strength the Sanofi India share price has outperformed the S&P BSE 100 Index by +15.88% over the past year.
What are the analyst and broker recommendations for Sanofi India?
The overall consensus recommendation for Sanofi India is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sanofi India dividend yield?
The Sanofi India dividend yield is 1.87% based on the trailing twelve month period.
Does Sanofi India pay a dividend?
Last year, Sanofi India paid a total dividend of IN₹117.00, and it currently has a trailing dividend yield of 1.87%.Looking ahead, the next dividend pay date is 2025-05-23.
When does Sanofi India next pay dividends?
We do not have data on when Sanofi India is to next pay dividends. The historic dividend yield on Sanofi India shares is currently 1.87%.
How do I buy Sanofi India shares?
To buy shares in Sanofi India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sanofi India?
As of the previous close price of IN₹6,273.00, shares in Sanofi India had a market capitalisation of IN₹139.66bn.
Where are Sanofi India shares listed?
Here are the trading details for Sanofi India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SANOFI
What kind of share is Sanofi India?
Based on an overall assessment of its quality, value and momentum Sanofi India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sanofi India share price forecast for 2025?
The analyst consensus target price for shares in Sanofi India is IN₹8,124.69. That is 29.52% above the last closing price of IN₹6,273.00.
Analysts covering Sanofi India currently have a consensus Earnings Per Share (EPS) forecast of IN₹173.40 for the next financial year.
Find out moreWhat is the trend in the Sanofi India share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sanofi India. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +0.54%.
As of the last closing price of IN₹6,273.00, shares in Sanofi India were trading +0.55% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sanofi India PE Ratio?
The Sanofi India PE ratio based on its reported earnings over the past 12 months is 37.6. The shares last closed at IN₹6,273.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sanofi India?
Sanofi India's management team is headed by:
- Aditya Narayan - NEC
- Vaibhav Karandikar - CFO
- Radhika Shah - CCO
- Rajaram Narayanan - MDR
- Cherian Mathew - EDR
- A. Sood - EDR
- Charles Billard - NED
- F. Briens - NED
- Rangaswamy Iyer - IND
- Usha Thorat - IND